Astrana Health, Inc. (ASTH) stock
ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3022% above fair value
$29.65−2.34 (-7.31%)
Close on Nov 18, 2026Market cap $1.65BP/E 36.2Yield –
Astrana Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Astrana Health's revenue for the twelve months ending Jun 30, 2026 was $3.84B, up 58.9% year over year. For fiscal 2025 it was $3.18B, up 56.4% from the year before. Over ten years it grew 82.5% a year on average. The highest annual figure on record is $3.18B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.18B | +56.4% |
| FY2024 | Dec 31, 2024 | $2.03B | +46.7% |
| FY2023 | Dec 31, 2023 | $1.39B | +21.2% |
| FY2022 | Dec 31, 2022 | $1.14B | +47.8% |
| FY2021 | Dec 31, 2021 | $773.92M | +12.6% |
| FY2020 | Dec 31, 2020 | $687.18M | +22.6% |
| FY2019 | Dec 31, 2019 | $560.62M | +7.8% |
| FY2018 | Dec 31, 2018 | $519.91M | +1080.3% |
| FY2016 | Mar 31, 2016 | $44.05M | +320.1% |
| FY2014 | Jan 31, 2014 | $10.48M | +34.8% |
| FY2013 | Jan 31, 2013 | $7.78M | +52.2% |
| FY2012 | Jan 31, 2012 | $5.11M | +31.2% |
| FY2011 | Jan 31, 2011 | $3.90M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $972.52M | +48.5% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $965.10M | +55.6% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $950.53M | +42.9% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $956.05M | +99.7% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $654.81M | +34.7% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $620.39M | +53.4% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $665.21M | +88.4% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $478.71M | +37.5% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $486.27M | +39.6% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $404.36M | +19.9% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $353.04M | +20.0% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $348.17M | +9.8% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $348.21M | +29.1% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $337.24M | +28.1% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $294.21M | +50.8% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $317.00M | +39.6% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $269.70M | +53.6% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $263.26M | +49.5% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $195.10M | +10.4% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $227.12M | +26.1% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $175.64M | +6.3% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $176.06M | +6.6% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $176.78M | -1.1% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $180.12M | +15.4% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $165.17M | +27.0% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $165.11M | +72.4% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $178.75M | +67.7% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $156.06M | -6.4% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $130.05M | +6.0% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $95.76M | -22.7% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $106.59M | +802.1% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $166.73M | +1464.1% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $122.67M | +978.9% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $123.92M | +1114.4% |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $11.82M | +316.1% |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | $10.66M | +309.2% |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | $11.37M | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | $10.20M | – |
| Q4 FY2014CQ4 2013 | Jan 31, 2014 | $2.84M | – |
| Q3 FY2014CQ3 2013 | Oct 31, 2013 | $2.61M | – |
See a number that looks wrong?